[Study of fetal alveolar surfactant: possibility of induction].
D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D000328:Adult; D002794:Choline / Q000031:analogs & derivatives*; D003566:Cytidine Diphosphate Choline / Q000494:pharmacology* / Q000627:therapeutic use; D005260:Female; D005333:Fetus / Q000187:drug effects; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D006819:Hyaline Membrane Disease / Q000517:prevention & control; D007231:Infant, Newborn; D011247:Pregnancy; D011650:Pulmonary Alveoli / Q000187:drug effects / Q000196:embryology*; D011663:Pulmonary Surfactants / Q000096:biosynthesis*; D012127:Respiratory Distress Syndrome, Newborn / Q000517:prevention & control
D000318:Adrenergic beta-Agonists; D005938:Glucocorticoids; D011663:Pulmonary Surfactants; D003566:Cytidine Diphosphate Choline; D002794:Choline
Studio sul surfattante alveolare fetale: possibilità di induzione.